Malaria Drug Chloroquine No Better Than Regular Coronavirus Care, Study Finds

  • Small study of 30 patients is early look at highly-touted drug
  • Medicine already being given to patients in New York
Trump Touts Drug, FDA Says Not Yet Approved
Lock
This article is for subscribers only.

We’re tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

Hydroxychloroquine, a medicine for malaria that President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found.